Financial News
Ocugen Inc (NQ: OCGN )
1.300
+0.030
(+2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Press Releases about Ocugen Inc
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen to Present at Retinal Vascular Disease Drug Development Summit
February 17, 2023
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen Appoints Quan A. Vu as Chief Business Officer
February 01, 2023
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference
January 31, 2023
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell
December 13, 2022
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit
November 28, 2022
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
November 08, 2022
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022
October 19, 2022
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2
October 12, 2022
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
September 29, 2022
From Ocugen
Via GlobeNewswire
![](https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2020)
![](https://www.marketbeat.com/logos/articles/small_stock-image_255386188_S.jpg)
![](https://mms.businesswire.com/media/20211008005592/en/1115286/4/2021-05-10-ksf-logo-sec-200.jpg)
Ocugen, Inc. (NASDAQ:OCGN) Long Term Investor Alert: Investigation of Potential Wrongdoing
September 28, 2021
Via SBWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20210910005567/en/1115286/4/2021-05-10-ksf-logo-sec-200.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27203.png)
![](https://storage.googleapis.com/accesswire/logos/share/1815.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/15063.png)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, OCGN and OTLY
August 16, 2021
From The Gross Law Firm
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/15063.png)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, AHCO and ATVI
August 15, 2021
From The Gross Law Firm
Via AccessWire
Exposures
Product Safety
![](https://mms.businesswire.com/media/20210813005427/en/538768/5/BES_Mark.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27203.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.